FDA Issues Complete Response Letter for AbbVie’s Fast-Acting Toxin Application
Agency requests additional manufacturing information and does not cite safety or efficacy concerns or require new clinical studies.
Agency requests additional manufacturing information and does not cite safety or efficacy concerns or require new clinical studies.
The tracking tools many plastic surgery practices rely on for digital advertising may be creating unintended compliance risks. As regulators increase scrutiny, standard website setups could expose patient data in ways that raise both HIPAA and FTC concerns.
New and pre-owned FDA-approved aesthetic devices are now available nationwide through an expanded sourcing model.
Expanded clearance allows the system to support hair removal and vascular lesion treatment using multiple wavelength configurations.
Dr David Pincus has introduced a $1,000 scholarship to support medical students pursuing careers in plastic surgery, emphasizing education, ethics, and patient-centered care.